RRAS2 and B-cell chronic lymphocytic leukemia: We have recently shown that overexpression of RRAS2 in its wild type form, but not its oncogenic mutant Q72L, drives the development of CLL in human patients and also in mouse models of human RRAS2 overexpression in B cells [19].